Angiotensin-Converting Enzyme InhibitorsEnalaprilSubstrate SpecificityCaptoprilLisinoprilAngiotensin Receptor AntagonistsEnzyme InhibitorsPerindoprilEnalaprilatAntihypertensive AgentsKineticsRamiprilAngiotensin II Type 1 Receptor BlockersCilazaprilTeprotideRenin-Angiotensin SystemHypertensionThiazepinesBlood PressureMolecular Sequence DataReninTetrazolesAmino Acid SequenceDiureticsAdrenergic beta-AntagonistsImidazolidinesTetrahydroisoquinolinesAngioedemaBinding Sites3-Mercaptopropionic AcidLosartanBradykininAngiotensin IIHeart FailurePeptidyl-Dipeptidase ACatalysisModels, MolecularKininsDrug Therapy, CombinationAngiotensin IBiphenyl CompoundsProteinuriaHydrolysisFosinoprilKidneyProtein BindingTime FactorsCatalytic DomainEscherichia coliRats, Inbred SHROligopeptidesSaralasinHydrogen-Ion ConcentrationDose-Response Relationship, DrugAngiotensinsRecombinant ProteinsCalcium Channel BlockersReceptors, BradykininHyperkalemiaImidazolesDipeptidesCrystallography, X-RayBenzimidazolesProlineStructure-Activity RelationshipProtease InhibitorsProtein ConformationAldosteroneIndolesSodium Chloride Symporter InhibitorsBase SequenceTreatment OutcomeCardiovascular AgentsHydrochlorothiazidePhosphorylationHydralazineMolecular StructureHypertension, RenalProtein Structure, TertiaryReceptor, Angiotensin, Type 1Oxidation-ReductionBenzazepinesMutationSequence Homology, Amino AcidMutagenesis, Site-DirectedReceptors, AngiotensinDouble-Blind MethodHemodynamicsValineRats, Sprague-DawleyDiabetic NephropathiesRats, Inbred WKYRats, WistarEnzyme ActivationMineralocorticoid Receptor AntagonistsKidney DiseasesIsoenzymesChromatography, High Pressure LiquidAdenosine TriphosphateAmlodipine